Becton Dickinson

Develops and sells medical devices and diagnostics

Eysins, Canton of Vaud, Switzerland

About Becton Dickinson

Becton Dickinson (BD) is a global medical technology firm that focuses on improving health through various segments, including BD Medical, BD Life Sciences, and BD Interventional. The company develops, manufactures, and sells medical devices, laboratory equipment, and diagnostic products to a diverse clientele, including hospitals and healthcare providers across multiple regions such as North America, Europe, Asia, and Latin America. BD's products are designed to enhance patient outcomes, reduce healthcare costs, and improve operational efficiencies. What sets BD apart from its competitors is its comprehensive approach to healthcare solutions, which not only addresses diagnostics and medical devices but also emphasizes safety and access to healthcare services. The company's goal is to advance healthcare by providing innovative solutions that support better patient care and operational effectiveness.

Eysins, SwitzerlandHeadquarters
1961Year Founded
$449.4KTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
Tuition Reimbursement

Risks

Increased competition in the pre-fillable syringe market.
Potential integration challenges with Cubex LLC's Medical Business assets.
Leadership changes may disrupt ongoing projects.

Differentiation

BD's global reach spans North America, EMEA, Greater Asia, and Latin America.
The company excels in medical devices, laboratory equipment, and diagnostic products.
BD's commitment to innovation enhances patient outcomes and operational efficiencies.

Upsides

$1.2B investment boosts syringe manufacturing and drug delivery systems.
Acquisition of Cubex LLC's assets strengthens BD's cloud-based healthcare solutions.
Federal funding supports expansion of COVID-19 test production capabilities.

Funding

Total raised$449.4 K
StageIPO
N/A